129 related articles for article (PubMed ID: 4401934)
21. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
Kubota M; Gotho Y; Furukawa K
Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
[No Abstract] [Full Text] [Related]
22. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
Gülker H; Kristek J; Heuer H; Bender F
Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
[TBL] [Abstract][Full Text] [Related]
23. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
[No Abstract] [Full Text] [Related]
24. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
Storstein L
Acta Med Scand; 1972 May; 191(5):423-8. PubMed ID: 4402323
[No Abstract] [Full Text] [Related]
25. A monitored release study. A clinical trial of oxprenolol in general practice.
Forrest WA
Practitioner; 1972 Mar; 208(245):412-6. PubMed ID: 4402044
[No Abstract] [Full Text] [Related]
26. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
Maranhão MF; da Cunha GP; Rojas RI
Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
[No Abstract] [Full Text] [Related]
27. [Beta adrenergic drugs in arterial hypertension].
Gysling E
Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
[No Abstract] [Full Text] [Related]
28. [A new beta-receptor blockader as anti-arrhythmic agent].
Dahlberg A
Lakartidningen; 1972 Mar; 69(12):1334-5. PubMed ID: 4402107
[No Abstract] [Full Text] [Related]
29. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
Forrest WA
Br J Clin Pract; 1972 May; 26(5):217-22. PubMed ID: 4625606
[No Abstract] [Full Text] [Related]
30. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
Lejwi G; Fabiato A; Gut JP; Gourgon R
Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
[No Abstract] [Full Text] [Related]
31. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
Bekes M; Matos L; Rausch J; Török E
Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
[No Abstract] [Full Text] [Related]
32. [What is assured in treatment with beta receptor blockaders?].
von Egidy H
Internist (Berl); 1972 Dec; 13(12):481-4. PubMed ID: 4405768
[No Abstract] [Full Text] [Related]
33. Combined treatment of atrial fibrillation with quinidine and beta-blockers.
Levi GF; Proto C
Br Heart J; 1972 Sep; 34(9):911-4. PubMed ID: 4403880
[No Abstract] [Full Text] [Related]
34. [Modified method for the testing of surface anesthesia on the rabbit cornea, using cocaine, procaine, propranolol, alprenolol, INPEA and verapamil].
Bartsch W; Knopf KW
Arzneimittelforschung; 1970 Aug; 20(8):1140-3. PubMed ID: 5536515
[No Abstract] [Full Text] [Related]
35. [Clinical study of a new beta-blocking agent: LB 46].
Warembourg H; Ducloux G
Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
[No Abstract] [Full Text] [Related]
36. [Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Miyazaki M; Nioka S; Fujita T
Masui; 1975 Jan; 24(1):56-63. PubMed ID: 1168741
[No Abstract] [Full Text] [Related]
37. [Therapeutic experiences with LB-46 (a new anti-arrhythmic agent) on arrhythmia during general anesthesia].
Tosaki Y; Yoshiya I; Yoshikawa K; Onji Y
Masui; 1971 Jan; 20(1):74-9. PubMed ID: 5102309
[No Abstract] [Full Text] [Related]
38. Potentiation of bronchomotor responses by beta adrenergic antagonists.
Diamond L
J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
[No Abstract] [Full Text] [Related]
39. Oxprenolol in Parkinson's disease.
Jackson R; Crawford CO; Peel JS
N Z Med J; 1971 Oct; 74(473):246-7. PubMed ID: 4399810
[No Abstract] [Full Text] [Related]
40. [Medium sized rings from alprenolol and oxprenolol].
Görlitzer K; Lorenz A
Pharmazie; 2004 Oct; 59(10):763-9. PubMed ID: 15544054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
